Our mission |
is to prolong human life and to improve its quality – in collaboration with medical doctors whom we consider to be our colleagues |
Pipeline
Actually there are some new pharmaceuticals under development and registration:
- peginterferon alfa-2b
- pegfilgrastim
- recombinant human blood coagulation Factor VII
- recombinant human blood coagulation Factor VIII
- bortezomib
In the frame of Presidential project related to organization of pilot production of substances and pharmaceuticals based on monoclonal antibodies we are developing the next medicines: - rituximab
- trastuzumab
- bevacizumab